Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sally Beauty Holdings (SBH) Asset Writedowns and Impairment (2022 - 2025)

Sally Beauty Holdings' Asset Writedowns and Impairment history spans 4 years, with the latest figure at $2.2 million for Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment rose 10442.86% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $4.9 million, up 280.62%, while the annual FY2025 figure was $5.4 million, 791.57% up from the prior year.
  • Asset Writedowns and Impairment reached $2.2 million in Q3 2025 per SBH's latest filing, up from $1.4 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $2.2 million in Q3 2025 to a low of -$338000.0 in Q1 2023.
  • Average Asset Writedowns and Impairment over 4 years is $1.0 million, with a median of $1.4 million recorded in 2023.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 101.55% in 2024, then soared 10442.86% in 2025.
  • A 4-year view of Asset Writedowns and Impairment shows it stood at $2.1 million in 2022, then tumbled by 35.62% to $1.4 million in 2023, then crashed by 101.55% to -$21000.0 in 2024, then skyrocketed by 10442.86% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for SBH's Asset Writedowns and Impairment are $2.2 million (Q3 2025), $1.4 million (Q2 2025), and -$21000.0 (Q3 2024).